| Line 9: |
Line 9: |
| | *[[Myeloproliferative Neoplasm (MPN), Unclassifiable]] | | *[[Myeloproliferative Neoplasm (MPN), Unclassifiable]] |
| | | | |
| − | ==Mastocytosis==
| |
| − |
| |
| − | *[[Cutaneous Mastocytosis]]
| |
| − | *[[Systemic Mastocytosis]]
| |
| − | *[[Mast Cell Sarcoma]]
| |
| − |
| |
| − | ==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2==
| |
| − |
| |
| − | *[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]]
| |
| − | *[[Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement]]
| |
| − | *[[Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement]]
| |
| − | *[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]]
| |
| − |
| |
| − | ==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)==
| |
| − |
| |
| − | *[[Chronic Myelomonocytic Leukemia (CMML)]]
| |
| − | *[[Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative]]
| |
| − | *[[Juvenile Myelomonocytic Leukemia (JMML)]]
| |
| − | *[[Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)|MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)]]
| |
| − | *[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]]
| |
| − |
| |
| − | ==Myelodysplastic Syndromes (MDS)==
| |
| − |
| |
| − | *[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]]
| |
| − | *[[Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)|MDS with Ring Sideroblasts (MDS-RS)]]
| |
| − | *[[Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia|MDS with Ring Sideroblasts and Multilineage Dysplasia]]
| |
| − | *[[Myelodysplastic Syndrome (MDS) with Multilineage Dysplasia|MDS with Multilineage Dysplasia]]
| |
| − | *[[Myelodysplastic Syndrome (MDS) with Excess Blasts|MDS with Excess Blasts]]
| |
| − | *[[Myelodysplastic Syndrome (MDS) with Isolated del(5q)|MSD with Isolated del(5q)]]
| |
| − | *[[Myelodysplastic Syndrome (MDS), Unclassifiable|MDS, Unclassifiable]]
| |
| − | *[[Refractory Cytopenia of Childhood]]
| |
| − |
| |
| − | ==Myeloid Neoplasms with Germline Predisposition==
| |
| − |
| |
| − | *[[Acute Myeloid Leukaemia with Germline CEBPA Mutation]]
| |
| − | *[[Myeloid Neoplasms with Germline DDX41 Mutation]]
| |
| − | *[[Myeloid Neoplasms with Germline RUNX1 Mutation]]
| |
| − | *[[Myeloid Neoplasms with Germline ANKRD26 Mutation]]
| |
| − | *[[Myeloid Neoplasms with Germline ETV6 Mutation]]
| |
| − | *[[Myeloid Neoplasms with Germline GATA2 Mutation]]
| |
| − |
| |
| − | ==Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms==
| |
| − |
| |
| − | *[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]]
| |
| − |
| |
| − | - [[Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1|AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]]
| |
| − | - [[Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11|AML with with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]]
| |
| − | - [[Acute Promyelocytic Leukemia (APL) with PML-RARA]]
| |
| − | - [[Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3|AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]]
| |
| − | - [[Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214|AML with t(6;9)(p23;q34.1); DEK-NUP214]]
| |
| − | - [[Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM|AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM]]
| |
| − | - [[Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1|AML Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1]]
| |
| − | - [[Acute Myeloid Leukemia (AML) with BCR-ABL1|AML with BCR-ABL1]]
| |
| − | - [[Acute Myeloid Leukemia (AML) with Mutated NPM1|AML with Mutated NPM1]]
| |
| − | - [[Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA|AML with Biallelic Mutations of CEBPA]]
| |
| − | - [[Acute Myeloid Leukemia (AML) with Mutated RUNX1|AML with Mutated RUNX1]]
| |
| − |
| |
| − | *[[Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes|AML with Myelodysplasia-Related Changes]]
| |
| − |
| |
| − | *[[Therapy-Related Myeloid Neoplasms]]
| |
| − |
| |
| − | *[[Acute Myeloid Leukemia (AML), Not Otherwise Specified|AML, Not Otherwise Specified]]
| |
| − |
| |
| − | - [[Acute Myeloid Leukemia (AML) with Minimal Differentiation|AML with Minimal Differentiation]]
| |
| − | - [[Acute Myeloid Leukemia (AML) without Maturation|AML without Maturation]]
| |
| − | - [[Acute Myeloid Leukemia (AML) with Maturation|AML with Maturation]]
| |
| − | - [[Acute Myelomonocytic Leukemia]]
| |
| − | - [[Acute Monoblastic and Monocytic Leukemia]]
| |
| − | - [[Pure Erythroid Leukemia]]
| |
| − | - [[Acute Megakaryoblastic Leukemia (AMKL)]]
| |
| − | - [[Acute Basophilic Leukemia]]
| |
| − | - [[Acute Panmyelosis with Myelofibrosis]]
| |
| − |
| |
| − | *[[Myeloid Sarcoma]]
| |
| − |
| |
| − | *[[Myeloid Proliferations Associated with Down Syndrome]]
| |
| − |
| |
| − | - [[Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome]]
| |
| − | - [[Myeloid Leukemia Associated with Down Syndrome]]
| |
| − |
| |
| − | ==Blastic Plasmacytoid Dendritic Cell Neoplasm==
| |
| − |
| |
| − | *[[Blastic Plasmacytoid Dendritic Cell Neoplasm]]
| |
| − |
| |
| − | ==Acute Leukemias of Ambiguous Lineage (MPAL)==
| |
| − |
| |
| − | *[[Acute Leukemias of Ambiguous Lineage]]
| |
| − |
| |
| − | - [[Acute Undifferentiated Leukemia]]
| |
| − | - [[Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1]]
| |
| − | - [[Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged]]
| |
| − | - [[Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified]]
| |
| − | - [[Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified]]
| |
| − | - [[Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types]]
| |
| − | - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]]
| |
| − |
| |
| − | ==Precursor Lymphoid Neoplasms (B-ALL, T-ALL)==
| |
| − |
| |
| − | *[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]]
| |
| − |
| |
| − | - [[B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1|B-ALL with t(9;22)(q34.1;q11.2); BCR-ABL1]]
| |
| − | - [[B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged|B-ALL with t(v;11q23.3); KMT2A-Rearranged]]
| |
| − | - [[B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1|B-ALL with t(12;21)(p13.2;q22.1); ETV6-RUNX1]]
| |
| − | - [[B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy|B-ALL with Hyperdiploidy]]
| |
| − | - [[B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy|B-ALL with Hypodiploidy]]
| |
| − | - [[B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3|B-ALL with t(5;14)(q31.1;q32.1); IGH/IL3]]
| |
| − | - [[B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1|B-ALL with t(1;19)(q23;p13.3); TCF3-PBX1]]
| |
| − | - [[B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like|B-ALL, BCR-ABL1-Like]]
| |
| − | - [[B-Lymphoblastic Leukemia/Lymphoma with iAMP21|B-ALL with iAMP21]]
| |
| − | - [[B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified|B-ALL, Not Otherwise Specified]]
| |
| − |
| |
| − | *[[T-Lymphoblastic Leukemia/Lymphoma|T-Lymphoblastic Leukemia/Lymphoma (T-ALL)]]
| |
| − |
| |
| − | - [[Early T-Cell Precursor Lymphoblastic Leukemia]]
| |
| − | - [[NK-Lymphoblastic Leukemia/Lymphoma]]
| |
| − |
| |
| − | ==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin Lymphomas)==
| |
| − |
| |
| − | *[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]]
| |
| − |
| |
| − | - [[Monoclonal B-cell Lymphocytosis]]
| |
| − |
| |
| − | *[[B-cell Prolymphocytic Leukemia]]
| |
| − |
| |
| − | *[[Splenic Marginal Zone Lymphoma]]
| |
| − |
| |
| − | *[[Hairy Cell Leukemia]]
| |
| − |
| |
| − | *[[Splenic B-cell Lymphoma/Leukemia, Unclassifiable]]
| |
| − |
| |
| − | - [[Splenic Diffuse Red Pulp Small B-cell Lymphoma]]
| |
| − | - [[Hairy Cell Leukemia Variant]]
| |
| − |
| |
| − | *[[Lymphoplasmacytic Lymphoma]]
| |
| − |
| |
| − | - [[Waldenstrom Macroglobulinemia]]
| |
| − |
| |
| − | *[[IgM Monoclonal Gammopathy of Undetermined Significance]]
| |
| − |
| |
| − | *[[Heavy Chain Diseases]]
| |
| − |
| |
| − | - [[Mu Heavy Chain Disease]]
| |
| − | - [[Gamma Heavy Chain Disease]]
| |
| − | - [[Alpha Heavy Chain Disease]]
| |
| − |
| |
| − | *[[Plasma Cell Neoplasms]]
| |
| − |
| |
| − | - [[Non-IgM Monoclonal Gammopathy of Undetermined Significance]]
| |
| − | - [[Plasma Cell Myeloma]]
| |
| − | - [[Plasma Cell Myeloma Variants]]
| |
| − | - [[Plasmacytoma]]
| |
| − | - [[Monoclonal Immunoglobulin Deposition Diseases]]
| |
| − | - [[Primary Amyloidosis]]
| |
| − | - [[Light Chain and Heavy Chain Deposition Disease]]
| |
| − | - [[Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome]]
| |
| − | - [[POEMS Syndrome]]
| |
| − | - [[TEMPI Syndrome]]
| |
| − |
| |
| − | *[[Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)]]
| |
| − |
| |
| − | *[[Nodal Marginal Zone Lymphoma]]
| |
| − |
| |
| − | - [[Paediatric Nodal Marginal Zone Lymphoma]]
| |
| − |
| |
| − | *[[Follicular Lymphoma]]
| |
| − |
| |
| − | - [[Testicular Follicular Lymphoma]]
| |
| − | - [[In Situ Follicular Neoplasia]]
| |
| − | - [[Duodenal-Type Follicular Lymphoma]]
| |
| − |
| |
| − | *[[Paediatric-Type Follicular Lymphoma]]
| |
| − |
| |
| − | *[[Large B-cell Lymphoma with IRF4 Rearrangement]]
| |
| − |
| |
| − | *[[Primary Cutaneous Follicle Centre Lymphoma]]
| |
| − |
| |
| − | *[[Mantle Cell Lymphoma]]
| |
| − |
| |
| − | - [[Leukemic Non-Nodal Mantle Cell Lymphoma]]
| |
| − | - [[In Situ Mantle Cell Neoplasia]]
| |
| − |
| |
| − | *[[Diffuse Large B-cell Lymphoma, Not Otherwise Specified]]
| |
| − |
| |
| − | *[[T-cell/Histiocyte-Rich Large B-cell Lymphoma]]
| |
| − |
| |
| − | *[[Primary Diffuse Large B-cell Lymphoma of the CNS]]
| |
| − |
| |
| − | *[[Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type]]
| |
| − |
| |
| − | *[[EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)]]
| |
| − |
| |
| − | *[[EBV-Positive Mucocutaneous Ulcer]]
| |
| − |
| |
| − | *[[Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation]]
| |
| − |
| |
| − | - [[Fibrin-Associated Diffuse Large B-cell Lymphoma]]
| |
| − |
| |
| − | *[[Lymphomatoid Granulomatosis]]
| |
| − |
| |
| − | *[[Primary Mediastinal (Thymic) Large B-cell Lymphoma]]
| |
| − |
| |
| − | *[[Intravascular Large B-cell Lymphoma]]
| |
| − |
| |
| − | *[[ALK-Positive Large B-cell Lymphoma]]
| |
| − |
| |
| − | *[[Plasmablastic Lymphoma]]
| |
| − |
| |
| − | *[[Primary Effusion Lymphoma]]
| |
| − |
| |
| − | *[[HHV8-Associated Lymphoproliferative Disorders]]
| |
| − |
| |
| − | - [[Multicentric Castleman Disease]]
| |
| − | - [[HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)]]
| |
| − | - [[HHV8-Positive Germinotropic Lymphoproliferative Disorder]]
| |
| − |
| |
| − | *[[Burkitt Lymphoma]]
| |
| − |
| |
| − | *[[Burkitt-Like Lymphoma with 11q Aberration]]
| |
| − |
| |
| − | *[[High-Grade B-cell Lymphoma]]
| |
| − |
| |
| − | - [[High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements]]
| |
| − | - [[High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)]]
| |
| − |
| |
| − | *[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]]
| |
| − |
| |
| − | ==Mature T- and NK-cell Neoplasms==
| |
| − |
| |
| − | *[[T-cell Prolymphocytic Leukemia]]
| |
| − |
| |
| − | *[[T-cell Large Granular Lymphocytic Leukemia]]
| |
| − |
| |
| − | *[[Chronic Lymphoproliferative Disorder of NK Cells]]
| |
| − |
| |
| − | *[[Aggressive NK-cell Leukemia]]
| |
| − |
| |
| − | *[[EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood]]
| |
| − |
| |
| − | - [[Systemic EBV-Positive T-cell Lymphoma of Childhood]]
| |
| − | - [[Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form]]
| |
| − | - [[Hydroa Vacciniforme-Like Lymphoproliferative Disorder]]
| |
| − | - [[Severe Mosquito Bite Allergy]]
| |
| − |
| |
| − | *[[Adult T-cell Leukemia/Lymphoma]]
| |
| − |
| |
| − | *[[Extranodal NK/T-cell Lymphoma, Nasal Type]]
| |
| − |
| |
| − | *[[Intestinal T-cell Lymphoma]]
| |
| − |
| |
| − | - [[Enteropathy-Associated T-cell Lymphoma]]
| |
| − | - [[Monomorphic Epitheliotropic Intestinal T-cell Lymphoma]]
| |
| − | - [[Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)]]
| |
| − | - [[Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract]]
| |
| − |
| |
| − | *[[Hepatosplenic T-cell Lymphoma]]
| |
| − |
| |
| − | *[[Subcutaneous Panniculitis-Like T-cell Lymphoma]]
| |
| − |
| |
| − | *[[Mycosis Fungoides]]
| |
| − |
| |
| − | *[[Sézary Syndrome]]
| |
| − |
| |
| − | *[[Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders]]
| |
| − |
| |
| − | - [[Lymphomatoid Papulosis]]
| |
| − | - [[Primary Cutaneous Anaplastic Large Cell Lymphoma]]
| |
| − |
| |
| − | *[[Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes]]
| |
| − |
| |
| − | - [[Primary Cutaneous Gamma Delta T-cell Lymphoma]]
| |
| − | - [[Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma]]
| |
| − | - [[Primary Cutaneous Acral CD8+ T-cell Lymphoma]]
| |
| − | - [[Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder]]
| |
| − |
| |
| − | *[[Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)]]
| |
| − |
| |
| − | *[[Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]]
| |
| − |
| |
| − | - [[Angioimmunoblastic T-cell Lymphoma]]
| |
| − | - [[Follicular T-cell Lymphoma]]
| |
| − | - [[Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype]]
| |
| − |
| |
| − | *[[Anaplastic Large Cell Lymphoma, ALK-Positive]]
| |
| − |
| |
| − | *[[Anaplastic Large Cell Lymphoma, ALK-Negative]]
| |
| − |
| |
| − | *[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]]
| |
| − |
| |
| − | ==Hodgkin Lymphomas==
| |
| − |
| |
| − | *[[Nodular Lymphocyte Predominant Hodgkin Lymphoma]]
| |
| − |
| |
| − | *Classic Hodgkin Lymphoma
| |
| − |
| |
| − | - [[Nodular Sclerosis Classic Hodgkin Lymphoma]]
| |
| − | - [[Lymphocyte-Rich Classic Hodgkin Lymphoma]]
| |
| − | - [[Mixed Cellularity Classic Hodgkin Lymphoma]]
| |
| − | - [[Lymphocyte-Depleted Classic Hodgkin Lymphoma]]
| |
| − |
| |
| − | ==Immunodeficiency-Associated Lymphoproliferative Disorders==
| |
| − |
| |
| − | *[[Lymphomas Associated with HIV Infection]]
| |
| − |
| |
| − | *[[Post-Transplant Lymphoproliferative Disorders]]
| |
| − |
| |
| − | - [[Non-Destructive Post-Transplant Lymphoproliferative Disorders]]
| |
| − | - [[Polymorphic Post-Transplant Lymphoproliferative Disorders]]
| |
| − | - [[Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)]]
| |
| − | - [[Monomorphic B-cell PTLD]]
| |
| − | - [[Monomorphic T/NK-cell PTLD]]
| |
| − | - [[Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder]]
| |
| − |
| |
| − | *[[Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]]
| |
| − |
| |
| − | ==Histiocytic and Dendritic Cell Neoplasms==
| |
| − |
| |
| − | *[[Histiocytic Sarcoma]]
| |
| − |
| |
| − | *[[Tumors Derived From Langerhans Cells]]
| |
| − |
| |
| − | - [[Langerhans Cell Histiocytosis]]
| |
| − | - [[Langerhans Cell Sarcoma]]
| |
| − |
| |
| − | *[[Indeterminate Dendritic Cell Tumour]]
| |
| − |
| |
| − | *[[Interdigitating Dendritic Cell Sarcoma]]
| |
| − |
| |
| − | *[[Follicular Dendritic Cell Sarcoma]]
| |
| − |
| |
| − | - [[Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma]]
| |
| − |
| |
| − | *[[Fibroblastic Reticular Cell Tumor]]
| |
| − |
| |
| − | *[[Disseminated Juvenile Xanthogranuloma]]
| |
| − |
| |
| − | *[[Erdheim-Chester Disease]]
| |
| | | | |
| | <comments /> | | <comments /> |